PDMR DEALING NOTIFICATION
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
a) |
Name |
Bharatt Chowrira |
||||||
2 |
Reason for the notification |
|||||||
a) |
Position/status |
President and Chief of Business and Strategy |
||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
PureTech Health plc |
||||||
b) |
LEI |
N/A |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||||
b) |
Nature of the transaction |
Pursuant to the terms of his Employment Agreement dated 1 March 2017, on 12 April 2017 PureTech Health plc granted two share options to Bharatt Chowrira. The first option in respect of 900,000 Ordinary Shares will vest in the following manner: 25% to vest on 1 March 2018, and remaining 75% shall vest in equal monthly instalments over the three years following 1 March 2018; provided that the option holder continues to be employed by PureTech Health plc on each such vesting date. The second option in respect of 300,000 Ordinary Shares will vest upon the achievement of a major business development inflection milestone (as defined in advance by the option holder and the CEO of PureTech Health plc); provided that the option holder continues to be employed by PureTech Health plc on each such vesting date. The options each have an exercise price of 114.25 pence per share. |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information
|
N/A |
||||||
e) |
Date of the transaction |
12 April 2017 |
||||||
f) |
Place of the transaction |
Outside a trading venue |